James Huang, Director at CASI Pharmaceuticals, holds 3.75M shares in Windtree Therapeutics (Ticker: WINT), holds 371.71K shares in CASI Pharmaceuticals (Ticker: CASI), holds 188.33K shares in Alaunos Therapeutics (Ticker: TCRT). Most recently, James Huang Bought ― shares of Windtree Therapeutics on Feb 23, 2023 for an estimated value of 155.72K.